Please login to the form below

Not currently logged in
Email:
Password:

atacicept

This page shows the latest atacicept news and features for those working in and with pharma, biotech and healthcare.

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Meanwhile, Merck suffered a setback in its mid-stage pipeline recently after its systemic lupus erythematosus (SLE) candidate atacicept failed to meet its objectives in a clinical trial, although it did

Latest news

  • Lupus – a 'great imitator'

    Atacicept is unique in that it is being developed solely for the treatment of lupus. ... Lupus nephritis trials have largely been unsuccessful, therefore it is hoped that, with the change in patient population, atacicept will show some efficacy in these

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics